← Back to Clinical Trials
Recruiting NCT07152509

NCT07152509 The Effect of Body Weight on Physical Activity Level, Functional Capacity, Balance, and Quality of Life in Individuals With Type 2 Diabetes Mellitus

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07152509
Status Recruiting
Phase
Sponsor Bezmialem Vakif University
Condition Type 2 Diabetes Mellitus (T2DM)
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2025-08-15
Primary Completion 2025-10-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Observational Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50 participants in total. It began in 2025-08-15 with a primary completion date of 2025-10-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effects of body weight on physical activity level, functional capacity, balance, and quality of life in patients with type 2 diabetes mellitus (T2DM). A total of 50 volunteer patients who meet the inclusion criteria will be recruited from the Internal Medicine and Nutrition outpatient clinics of Bezmialem Vakıf University Hospital. Participants will be prospectively evaluated through face-to-face interviews. Assessments will include body composition analysis (Omron Body Composition Monitor), waist-to-hip ratio, lower extremity muscle strength (Muscle Hand-Held Dynamometer), grip strength (Hand Grip Dynamometer), physical activity level (International Physical Activity Questionnaire-Short Form), functional capacity (6-Minute Walk Test), balance (Biodex Balance System), clinical balance (Berg Balance Scale), and quality of life (Nottingham Health Profile). All statistical analyses will be performed using IBM SPSS Statistics 20. With this study, we aim to comprehensively evaluate multiple parameters in individuals with T2DM and investigate their interrelationships, thereby contributing to the current body of knowledge in the literature.

Eligibility Criteria

Inclusion Criteria: * Having a diagnosis of Type 2 Diabetes Mellitus for at least 1 year * Being between 18 and 65 years of age * Having an HbA1c value between 6.5% and 11% at the time of diagnosis * No cognitive or mental problems * Ability to walk independently * Willingness to participate in the study Exclusion Criteria: * Presence of uncontrolled cardiovascular and pulmonary disease * Presence of vertigo or various vestibular system disorders * Presence of severe neurological or respiratory disease * History of stroke or myocardial infarction * Presence of a major musculoskeletal problem * Presence of chronic renal failure * Presence of diabetic ulcer or neuropathy * Pregnancy * Presence of hemolytic or renal anemia * Presence of serious visual, hearing, or speech impairments leading to lack of cooperation

Contact & Investigator

Central Contact

ŞULE TOPÇU ŞAHİN, PhD (c)

✉ fztsuletopcu@gmail.com

📞 +90 5398566970

Principal Investigator

SEMİRAMİS ÖZYILMAZ, Assoc. Prof.

PRINCIPAL INVESTIGATOR

Bezmialem Vakıf University,Facult Of Health Sciences, Department Of Physiotherapy And Rehabilitation

Frequently Asked Questions

Who can join the NCT07152509 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Type 2 Diabetes Mellitus (T2DM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07152509 currently recruiting?

Yes, NCT07152509 is actively recruiting participants. Contact the research team at fztsuletopcu@gmail.com for enrollment information.

Where is the NCT07152509 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07152509 clinical trial?

NCT07152509 is sponsored by Bezmialem Vakif University. The principal investigator is SEMİRAMİS ÖZYILMAZ, Assoc. Prof. at Bezmialem Vakıf University,Facult Of Health Sciences, Department Of Physiotherapy And Rehabilitation. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology